Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Data

v3.24.3
Selected Balance Sheet Data
3 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Supplemental Balance Sheet and Cash Flow Information

Note 3. Selected Balance Sheet Data:

Inventories:

Inventories consist of (in thousands):

    

September 30, 

June 30, 

    

2024

    

2024

Raw materials

$

81,786

$

79,377

Finished goods(1)

 

108,811

 

106,072

Inventories, net

$

190,597

$

185,449

(1) Finished goods inventory of $5,556 and $5,718 is included within Other Assets in the September 30, 2024 and June 30, 2024, Consolidated Balance Sheets, respectively, as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.

Property and Equipment:

Property and equipment consist of (in thousands):

    

September 30, 

June 30, 

    

2024

    

2024

Land

$

8,161

$

8,150

Buildings and improvements

 

250,206

 

243,863

Machinery and equipment

228,648

215,948

Construction in progress

 

32,186

 

39,749

Property and equipment, cost

 

519,201

 

507,710

Accumulated depreciation and amortization

 

(265,262)

 

(256,556)

Property and equipment, net

$

253,939

$

251,154

Intangible Assets:

Intangible assets consist of (in thousands):

September 30, 

June 30, 

2024

2024

Developed technology

$

680,747

$

675,674

Tradenames

 

152,341

 

151,561

Customer relationships

 

212,011

 

211,276

Patents

 

4,552

 

4,343

Other intangibles

 

7,176

 

12,006

Definite-lived intangible assets

 

1,056,827

 

1,054,860

Accumulated amortization

 

(570,823)

 

(547,779)

Total intangible assets, net

$

486,004

$

507,081

Changes to the carrying amount of net intangible assets for the period ended September 30, 2024 consist of (in thousands):

    

September 30, 

2024

Beginning balance

$

507,081

Other additions

 

112

Amortization expense

 

(20,040)

Restructuring impairment

(5,474)

Currency translation

4,325

Ending balance

$

486,004

The estimated future amortization expense for intangible assets as of September 30, 2024 is as follows (in thousands):

Remainder 2025

    

$

59,111

2026

 

72,743

2027

 

62,540

2028

 

58,821

2029

 

46,200

Thereafter

 

186,589

Total

$

486,004

Goodwill:

Changes to the carrying amount of goodwill for the period ended September 30, 2024 consist of (in thousands):

    

    

Diagnostics and

    

Protein Sciences

 Spatial Biology

Total

June 30, 2024

$

423,449

$

549,214

$

972,663

Currency translation

 

3,042

6,880

9,922

September 30, 2024

$

426,491

$

556,094

$

982,585

We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a qualitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2024. No indicators of impairment were identified as part of our assessment.

Other assets:

Other assets consist of (in thousands):

    

September 30, 

June 30,

    

2024

2024

Equity method investment in Wilson Wolf

$

241,308

$

242,337

Derivative instruments

6,669

9,813

Long-term inventory

5,556

5,718

Investment in Spear Bio

15,000

Other

 

7,168

 

6,397

Other assets

$

275,701

$

264,265